Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome

AIM:To investigate the therapeutic outcomes of idiopathic retinal vasculitis, aneurisms and neuroretinitis(IRVAN)syndrome by different treatments. <p>METHODS:Seven patients(14 eyes)with IRVAN were enrolled in this study and divided into different stages. There were 4 eyes in stage Ⅱ and 10 eye...

Full description

Bibliographic Details
Main Authors: Ling Shao, Shu Yan, Min Du, Bao-Di Qiao
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2016-04-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2016/4/201604047.pdf
_version_ 1798044707351166976
author Ling Shao
Shu Yan
Min Du
Bao-Di Qiao
author_facet Ling Shao
Shu Yan
Min Du
Bao-Di Qiao
author_sort Ling Shao
collection DOAJ
description AIM:To investigate the therapeutic outcomes of idiopathic retinal vasculitis, aneurisms and neuroretinitis(IRVAN)syndrome by different treatments. <p>METHODS:Seven patients(14 eyes)with IRVAN were enrolled in this study and divided into different stages. There were 4 eyes in stage Ⅱ and 10 eyes in stage Ⅲ. The visual acuity(VA)was ≥0.6 in 6 eyes, 0.3 in 4 eyes, and ≤0.1 in 4 eyes. Treatment involved retinal laser photocoagulation for peripheral retinal ischemia area in the 4 eyes in stage Ⅱ and panretinal laser photocoagulation(PRP)for the 10 eyes in stage Ⅲ. Two eyes in stage Ⅲ were also treated with intravitreal injection of ranibizumab and 4 eyes with vitrectomy before PRP. Visual acuity and fundus situations were measured after the treatments. The follow-up time was 6mo ~ 10a. <p>RESULTS:After treatments, the final VA was improved in 6 eyes, remaining unchanged in 6 eyes, and decreased after improved in 2 eyes. It was as following:≥0.6 in 9 eyes, 0.3~0.6 in 4 eyes, and ≤0.1 in 1 eyes. Four eyes in stage Ⅱ maintained a good vision, but one of them had a new ischemia area. We treated it with PRP and there was no progression now. In stage Ⅲ, there were 2 eyes with unchanged VA, 2 eyes with improved VA, 2 eyes with improved VA after giving ranibizumab, 4 eyes with vitreous hemorrhage and with better VA after treatments, and in the 4 eyes, 2 eyes kept stable and another two had recurrent vitreous hemorrhage for several times and ended with poor vision. Fundus examination showed the closure of hemorrhage area and optic disc or retinal neovascularization shrinked.<p>CONCLUSION:PRP is effective for eyes in stage Ⅱ. Eyes in stage Ⅲ could be treated with intravitreal injection of ranibizumab or vitrectomy in addition to PRP. Early PRP is effective to stop the progression.
first_indexed 2024-04-11T23:08:29Z
format Article
id doaj.art-59d6efef403440c29393465e1d222e9f
institution Directory Open Access Journal
issn 1672-5123
1672-5123
language English
last_indexed 2024-04-11T23:08:29Z
publishDate 2016-04-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series Guoji Yanke Zazhi
spelling doaj.art-59d6efef403440c29393465e1d222e9f2022-12-22T03:57:55ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232016-04-0116476476610.3980/j.issn.1672-5123.2016.4.47Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndromeLing Shao0Shu Yan1Min Du2Bao-Di Qiao3Zhengzhou Eye Hospital, Zhengzhou Second Hospital, Zhengzhou 450006, Henan Province, ChinaZhengzhou Eye Hospital, Zhengzhou Second Hospital, Zhengzhou 450006, Henan Province, ChinaZhengzhou Eye Hospital, Zhengzhou Second Hospital, Zhengzhou 450006, Henan Province, ChinaZhengzhou Eye Hospital, Zhengzhou Second Hospital, Zhengzhou 450006, Henan Province, ChinaAIM:To investigate the therapeutic outcomes of idiopathic retinal vasculitis, aneurisms and neuroretinitis(IRVAN)syndrome by different treatments. <p>METHODS:Seven patients(14 eyes)with IRVAN were enrolled in this study and divided into different stages. There were 4 eyes in stage Ⅱ and 10 eyes in stage Ⅲ. The visual acuity(VA)was ≥0.6 in 6 eyes, 0.3 in 4 eyes, and ≤0.1 in 4 eyes. Treatment involved retinal laser photocoagulation for peripheral retinal ischemia area in the 4 eyes in stage Ⅱ and panretinal laser photocoagulation(PRP)for the 10 eyes in stage Ⅲ. Two eyes in stage Ⅲ were also treated with intravitreal injection of ranibizumab and 4 eyes with vitrectomy before PRP. Visual acuity and fundus situations were measured after the treatments. The follow-up time was 6mo ~ 10a. <p>RESULTS:After treatments, the final VA was improved in 6 eyes, remaining unchanged in 6 eyes, and decreased after improved in 2 eyes. It was as following:≥0.6 in 9 eyes, 0.3~0.6 in 4 eyes, and ≤0.1 in 1 eyes. Four eyes in stage Ⅱ maintained a good vision, but one of them had a new ischemia area. We treated it with PRP and there was no progression now. In stage Ⅲ, there were 2 eyes with unchanged VA, 2 eyes with improved VA, 2 eyes with improved VA after giving ranibizumab, 4 eyes with vitreous hemorrhage and with better VA after treatments, and in the 4 eyes, 2 eyes kept stable and another two had recurrent vitreous hemorrhage for several times and ended with poor vision. Fundus examination showed the closure of hemorrhage area and optic disc or retinal neovascularization shrinked.<p>CONCLUSION:PRP is effective for eyes in stage Ⅱ. Eyes in stage Ⅲ could be treated with intravitreal injection of ranibizumab or vitrectomy in addition to PRP. Early PRP is effective to stop the progression.http://ies.ijo.cn/cn_publish/2016/4/201604047.pdfidiopathic retinal vasculitisaneurisms and neuroretinitis syndrometherapyretinal vasculitispanretinal laser photocoagulation
spellingShingle Ling Shao
Shu Yan
Min Du
Bao-Di Qiao
Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome
Guoji Yanke Zazhi
idiopathic retinal vasculitis
aneurisms and neuroretinitis syndrome
therapy
retinal vasculitis
panretinal laser photocoagulation
title Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome
title_full Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome
title_fullStr Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome
title_full_unstemmed Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome
title_short Treatment and therapeutic effect of idiopathic retinal vasculitis, aneurisms and neuroretinitis syndrome
title_sort treatment and therapeutic effect of idiopathic retinal vasculitis aneurisms and neuroretinitis syndrome
topic idiopathic retinal vasculitis
aneurisms and neuroretinitis syndrome
therapy
retinal vasculitis
panretinal laser photocoagulation
url http://ies.ijo.cn/cn_publish/2016/4/201604047.pdf
work_keys_str_mv AT lingshao treatmentandtherapeuticeffectofidiopathicretinalvasculitisaneurismsandneuroretinitissyndrome
AT shuyan treatmentandtherapeuticeffectofidiopathicretinalvasculitisaneurismsandneuroretinitissyndrome
AT mindu treatmentandtherapeuticeffectofidiopathicretinalvasculitisaneurismsandneuroretinitissyndrome
AT baodiqiao treatmentandtherapeuticeffectofidiopathicretinalvasculitisaneurismsandneuroretinitissyndrome